Change in hepatitis C virus genotype in injecting drug users

Journal of Medical Virology

Volumn 74, Issue 4, 2004, Pages 543-545

  Aitken, Campbell ^a   McCaw, Rhonda ^c   Jardine, Darren ^b   Bowden, Scott ^c   Higgs, Peter ^a   Nguyen, Oanli ^a   Crofts, Nick ^a   Hellard, Margaret ^a  

^a BURNET INSTITUTE   (Australia)

^b National Serology Reference Laboratory   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Genotype variability; HCV incidence; Illicit drug users; Infection dynamics

Indexed keywords

ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL ARTICLE; DRUG USE; DYNAMICS; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN; INCIDENCE; NONHUMAN; VIRUS INFECTION;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS C VIRUS;

EID: 7044249352     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20212     Document Type: Article

References (14)

1. Accapezzato D, Fravolini F, Casciaro MA, Paroli M. 2002. Hepatitis C flare due to superinfection by genotype 4 in an HCV genotype 1b chronic carrier. Eur J Gastroenterol Hepatol 14:879-881.
2. Asselah T, Vidaud D, Doloy A, Boyer N, Martinet M, Vidaud M, Valla D, Marcellin P. 2003. Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy. Gut 52:900-902.
3. Brown RS, Jr., Gaglio PJ. 2003. Scope of worldwide hepatitis C problem. Liver Transpl 9:S10-S13.
4. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein RS. 2003. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 157:467-471.
5. Dev A, McCaw R, Sundararajan V, Bowden S, Sievert W. 2002. Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome. Hepatology 36:1259-1265.
6. Giannini C, Giannelli F, Monti M, Careccia G, Marrocchi ME, Laffi G, Gentilini P, Zignego AL. 1999. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 134:68-73.
7. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. 2002. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J Infect Dis 186:1558-1564.
8. Hu YW, Balaskas E, Furione M, Yen PH, Kessler G, Scalia V, Chui L, Sher G, 2000. Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections. J Clin Microbiol 38:2807-2813.
9. Laskus T, Wang LF, Radkowski M, Nowicki M, Wilkinson J, Rakela J. 2001. Exposure of hepatitis C virus-negative recipients to > or = 2 infected blood donors. J Infect Dis 183:666-669.
10. Proust B, Dubois F, Bacq Y, Le Pogam S, Rogez S, Levillain R, Goudeau A. 2000. Two successive hepatitis C virus infections in an intravenous drug user. J Clin Microbiol 38:3125-3127.
11. Schroter M, Feucht HH, Zollner B, Schafer P, Laufs R. 2003. Multiple infections with different HCV genotypes: Prevalence and clinical impact. J Clin Virol 27:200-204.
12. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechet C, Brouwer JT, Chan SW, Chayama K, Chen DS, et al. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
13. Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. 2000. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343:1666-1672.
14. Zhang S, Hui Z, Li H, Qi Z, Widell A. 2001. Dynamic changes in hepatitis C virus genotypes and sequence patterns in plasma donors exposed to reinfection. J Med Virol 63:228-236.